Q: In the requirements page, it says that I need a "Final GROMACS MD trajectory, fitted and with no pbc". Here, does "no pbc" mean a trajectory whose pbc effects have been removed? And by "fitted", does it mean that I should process the pbc-corrected trajectory with "-fit rot+trans"?
Q: In the paper, it says that Single Trajectory Protocol (STP) "...is valid when the bound and unbound states of the receptor and the ligand are similar". But what does "similar" mean here? Structurally similar? Does it mean that, if I have a long ligand (like the grey molecule in the figure below), this method may not be appropriate because the ligand binds at a conformation that is far from the average in the unbound state? In that case, would it be preferable to use Multiple Trajectory Protocol (MTP)?
Q: Is there any recommended simulation length and/or number of frames to extract in total or per nanosecond with gmx_MMPBSA?
Q: For the usual MM/PB(GB)SA calculation, is gmx_MMPBSA generally suitable for good working laptops (e.g., I have dedicated 4 cores and 8 GB RAM to an Ubuntu virtual machine), or is an HPC cluster recommended?
All and all, if you are interested in performing alanine scanning or binding free energy calculations with implicit solvents, our software provides more robustness and flexibility. For a thorough comparison with other software used for similar purposes, check here (
https://valdes-tresanco-ms.github.io/gmx_MMPBSA/dev/versus)
Hope this helps!
Let us know if you have further questions...
gmx_MMPBSA team